Literature DB >> 33003257

Comments for better understanding of the study clinical characteristics and prognostic factors in COVID-19 patients aged ≥80 years.

Veerendra Kumar Arumalla1, Aruna Bholenath Patil2.   

Abstract

Entities:  

Mesh:

Year:  2020        PMID: 33003257      PMCID: PMC7537513          DOI: 10.1111/ggi.14008

Source DB:  PubMed          Journal:  Geriatr Gerontol Int        ISSN: 1447-0594            Impact factor:   2.730


× No keyword cloud information.
Dear Editor, We have read with interest the original article from authors Covino et al. entitled “Clinical characteristics and prognostic factors in COVID‐19 patients aged ≥80 years.” The authors aimed to describe the clinical presentation of patients aged ≥80 years with coronavirus disease 2019 (COVID‐19), and provide insights regarding the prognostic factors and the risk stratification in this population. Consequently, the authors conclude that the risk of death could not be age dependent in patients aged ≥80 years, whereas severe dementia emerged as a relevant risk factor for death in this population. However, we have some comments related to this study. “Severe Dementia” was not defined in the methodology. The comparison was made between patients with severe dementia where two survived and six died, which was found statistically significant. However, the study found only eight of 69 (11.6%) patients with dementia. Importantly, we should not ignore 17 of 23 (74%) patients who had died because of other comorbidities without dementia. The study concluded that risk of death could not be age dependent in patients aged ≥80 years. On the contrary, the case fatality rate of COVID‐19 increases with old age. In addition, the presence of comorbidities was found associated with greater disease severity and poor clinical outcomes, hence risk increases with the number of comorbidities a patient has. While comparing comorbidities, the authors found there was no statistically significant difference between patients with COVID‐19 that survived versus those that died. Age along with the number of comorbidities with duration and severity would have played an important role in the primary endpoint of the study, i.e., death. One statement of confusion was that dementia was an independent risk factor for death in the discussion yet was a relevant risk factor in the conclusion. For an identical age group (≥80 years) using a study with this small sample size, severe dementia probably may not be the independent risk factor for death due to COVID‐19, but definitely it may act as an independent risk factor if a study includes patients from all age groups, controlling for all possible risk factors. It would have been better if the study could include more descriptive statistics for statistically significant variables found in the patients who died. It might have helped us to understand more about the prognostic factors among elderly patients with COVID‐19.

Disclosure statement

The authors declare no conflict of interest.
  5 in total

Review 1.  In search of fewer independent risk factors.

Authors:  Daniel J Brotman; Esteban Walker; Michael S Lauer; Ralph G O'Brien
Journal:  Arch Intern Med       Date:  2005-01-24

2.  Estimates of the severity of coronavirus disease 2019: a model-based analysis.

Authors:  Robert Verity; Lucy C Okell; Ilaria Dorigatti; Peter Winskill; Charles Whittaker; Natsuko Imai; Gina Cuomo-Dannenburg; Hayley Thompson; Patrick G T Walker; Han Fu; Amy Dighe; Jamie T Griffin; Marc Baguelin; Sangeeta Bhatia; Adhiratha Boonyasiri; Anne Cori; Zulma Cucunubá; Rich FitzJohn; Katy Gaythorpe; Will Green; Arran Hamlet; Wes Hinsley; Daniel Laydon; Gemma Nedjati-Gilani; Steven Riley; Sabine van Elsland; Erik Volz; Haowei Wang; Yuanrong Wang; Xiaoyue Xi; Christl A Donnelly; Azra C Ghani; Neil M Ferguson
Journal:  Lancet Infect Dis       Date:  2020-03-30       Impact factor: 25.071

3.  Clinical characteristics and prognostic factors in COVID-19 patients aged ≥80 years.

Authors:  Marcello Covino; Giuseppe De Matteis; Michele Santoro; Luca Sabia; Benedetta Simeoni; Marcello Candelli; Veronica Ojetti; Francesco Franceschi
Journal:  Geriatr Gerontol Int       Date:  2020-06-09       Impact factor: 2.730

4.  Comorbidity and its impact on 1590 patients with COVID-19 in China: a nationwide analysis.

Authors:  Wei-Jie Guan; Wen-Hua Liang; Yi Zhao; Heng-Rui Liang; Zi-Sheng Chen; Yi-Min Li; Xiao-Qing Liu; Ru-Chong Chen; Chun-Li Tang; Tao Wang; Chun-Quan Ou; Li Li; Ping-Yan Chen; Ling Sang; Wei Wang; Jian-Fu Li; Cai-Chen Li; Li-Min Ou; Bo Cheng; Shan Xiong; Zheng-Yi Ni; Jie Xiang; Yu Hu; Lei Liu; Hong Shan; Chun-Liang Lei; Yi-Xiang Peng; Li Wei; Yong Liu; Ya-Hua Hu; Peng Peng; Jian-Ming Wang; Ji-Yang Liu; Zhong Chen; Gang Li; Zhi-Jian Zheng; Shao-Qin Qiu; Jie Luo; Chang-Jiang Ye; Shao-Yong Zhu; Lin-Ling Cheng; Feng Ye; Shi-Yue Li; Jin-Ping Zheng; Nuo-Fu Zhang; Nan-Shan Zhong; Jian-Xing He
Journal:  Eur Respir J       Date:  2020-05-14       Impact factor: 16.671

5.  Comments for better understanding of the study clinical characteristics and prognostic factors in COVID-19 patients aged ≥80 years.

Authors:  Veerendra Kumar Arumalla; Aruna Bholenath Patil
Journal:  Geriatr Gerontol Int       Date:  2020-10       Impact factor: 2.730

  5 in total
  2 in total

1.  Authors' reply to: Comment to better understanding of the study "Clinical characteristics and prognostic factors in COVID-19 patients aged ≥80 years".

Authors:  Marcello Covino; Giuseppe De Matteis; Francesco Franceschi
Journal:  Geriatr Gerontol Int       Date:  2020-10-04       Impact factor: 2.730

2.  Comments for better understanding of the study clinical characteristics and prognostic factors in COVID-19 patients aged ≥80 years.

Authors:  Veerendra Kumar Arumalla; Aruna Bholenath Patil
Journal:  Geriatr Gerontol Int       Date:  2020-10       Impact factor: 2.730

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.